SAN DIEGO, Feb. 07, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at 1:00 p.m. EST on Tuesday, February 14, at the Biotechnology Innovation Organization (BIO) CEO and Investor Conference (New York – February 13-14). A webcast of the company’s presentation will be available live and archived through the Events & Presentations page in the Investors section of the Vical website at www.vical.com.

About Vical
Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on its patented DNA delivery technologies and other therapeutic approaches. Additional information on Vical is available at www.vical.com.

Contact: 
Tony Ramos
(858) 646-1127
Website: www.vical.com

Primary Logo